SK bioscience, the biopharmaceutical arm of South Korea's SK Group, said on Wednesday it has achieved a "final victory" in a ...

SEOUL, April 23 (Yonhap) -- SK bioscience Co., the biopharmaceutical arm of South Korea's SK Group, said Wednesday it has ...

South Korean vaccine developer SK bioscience has won a final ruling in a patent dispute with Moderna (Nasdaq: MRNA) over key ...

SK Bioscience announced Wednesday that it has secured a definitive legal victory in its patent invalidation suit against Moderna, successfully challenging the biotech giant’s Korean patent related to ...

Sanofi has moved ahead with plans to challenge Pfizer and MSD for a piece of the market for pneumococcal vaccines, taking a 21-valent shot licensed from SK Biosciences into phase 3 testing.

Got a new vaccine? Korea can make it for you.

Sanofi SNY has expanded its existing agreement with SK bioscience to develop, license and commercialize next-generation PCVs for treating IPD in pediatric and adult patient populations in December ...

Norwegian Ambassador to Korea; H.E. Ban Ki-moon, 8th UN Secretary-General; Dr. Tore Godal; Dr. Jerome Kim, Director General of IVI; Dr. Hun Kim, Chief Technology Officer of SK bioscience ...

The birth of the dire wolf came after Colossal Biosciences revealed that it had ... Pallavi has been a celebrity trends writer at SK POP since 2023. She holds a Master's degree in English from ...